NMTC - NeuroOne Medical Technologies Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
2.0000
+0.1400 (+7.53%)
As of 11:13AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.8600
Open2.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.0000 - 2.0000
52 Week Range1.2100 - 9.8900
Volume4,482
Avg. Volume8,389
Market Cap26.98M
Beta (3Y Monthly)-0.64
PE Ratio (TTM)N/A
EPS (TTM)-0.7310
Earnings DateAug 14, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE

    NeuroOne Medical Technologies Corporation Provides Update on 510(k) Submission to the FDA

    MINNETONKA, MN / ACCESSWIRE / October 1, 2019 / NeuroOne Medical Technologies Corporation (NMTC), a medical device company focused on the development and commercialization of thin-film electrode technology for recording brain activity, stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson's Disease, and back pain, today announced that it has re-submitted its 510(k) submission to the United States Food and Drug Administration (FDA) for its cortical electrode technology. On August 14, 2019, the Company announced that it had withdrawn its initial 510(k) submission for its cortical electrode technology after the FDA requested additional sterilization data related to the cable assembly that could not be provided within the time period specified by the FDA.

  • ACCESSWIRE

    NeuroOne(TM) Medical Technologies Corporation Announces First Sale of sEEG Depth Electrode

    MINNETONKA, MN / ACCESSWIRE / September 23, 2019 / NeuroOne Medical Technologies Corporation (NMTC), a medical device company focused on the development and commercialization of thin film electrode technology for recording brain activity, stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson's Disease, and back pain, today announced its first product sale to the Cleveland Clinic for non-human research applications. The NeuroOne sEEG combination depth and ablation electrode is not currently cleared or approved for human use in the United States or internationally and has not yet been reviewed by FDA nor any international regulatory bodies. The device is intended to be used to perform recording of brain activity up to 30 days, short term brain tissue stimulation and offer radio frequency tissue ablation properties all within the same device.

  • ACCESSWIRE

    NeuroOne Medical Technologies Corporation: Announces Fiscal Third Quarter 2019 Financial Results and Provides a Corporate Update

    MINNETONKA, MN / ACCESSWIRE / August 14, 2019 / NeuroOne Medical Technologies Corporation (OTCQB:NMTC) , a medical device company focused on the development and commercialization of thin film electrode ...

  • ACCESSWIRE

    NeuroOne Medical Technologies Corporation Appoints Chief Technology Officer

    MINNETONKA, MN / ACCESSWIRE / April 15, 2019 / NeuroOne Medical Technologies Corporation (NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the hiring of Steve Mertens as Chief Technology Officer. "As we transition from a development-stage company to a commercial entity, I'm looking forward to having Steve as part of our team," said NeuroOne's President and CEO Dave Rosa.

  • GlobeNewswire

    NeuroOne Medical Technologies Announces Hiring Of Senior Staff

    NeuroOne Medical Technologies Corporation (NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the hiring of Leah Noaeill as Senior Director of Marketing and Scott Heuler as Vice President of Sales to establish the company’s U.S. commercial organization and drive any future product launches. “Leah and Scott’s deep organizational and commercial expertise will be invaluable in our continued evolution as an innovator of neurological technology,” said NeuroOne CEO Dave Rosa. Mrs. Noaeill comes to NeuroOne with fifteen years in medical device marketing in a connected healthcare environment.

  • GlobeNewswire

    NeuroOne Medical Technologies Corporation Announces Appointments to Artificial Intelligence Advisory Board

    NeuroOne Medical Technologies Corporation (NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, introduced five members that have been appointed to the Company’s new Artificial Intelligence Advisory Board. In the third quarter of 2018, the Company announced the formation of a seven member advisory board to be chaired by Dr. Kip Ludwig of the Bioelectronic Medicines Laboratory at the University of Wisconsin.